$Harmony Biosciences(HRMY.US)$ NEWS HARMONY BIOSCIENCES HOLDINGS INC: POTENTIAL PAYMENTS OF UP TO $515 MLN IF CERTAIN SALES MILESTONES ARE ACHIEVED HARMONY BIOSCIENCES Q1 PRETAX PROFIT USD 51.785 MILLION VS. IBES ESTIMATE USD 47.9 MILLION
Harmony Biosciences Holdings' conservative balance sheet and net cash position suggest safe debt management. The company's impressive EBIT growth over the last year aids in handling its debt. Its use of debt is not deemed risky.
Despite expected EPS growth, Harmony Biosciences' low P/E ratio signals bearishness as skeptics question its ability to improve declining earnings, potentially capping its stock price. The P/E and growth outlook mismatch suggests investor concerns about unexpected earnings threats.
Pre-Market Stock Movers Gapping up $亚马逊(AMZN.US)$stock rose 0.5% after the tech giant announced plans to invest up to $4 billion in artificial intelligence group Anthropic, in an attempt to bolster its position in nascent AI technology. $Warner Bros Discovery(WBD.US)$stock rose 2.1%,$奈飞(NFLX.US)$rose 0.8% and$迪士尼(DIS.US)$rose 1.1% as these entertainment giants benefited from the news that Hollywood's wr...
Harmony Biosciences股票讨论区
ADDITIONAL
HARMONY BIOSCIENCES HOLDINGS INC: REITERATES 2024 NET PRODUCT REVENUE GUIDANCE OF $700 - $720 MLN
NEWS
HARMONY BIOSCIENCES HOLDINGS INC: POTENTIAL PAYMENTS OF UP TO $515 MLN IF CERTAIN SALES MILESTONES ARE ACHIEVED
HARMONY BIOSCIENCES Q1 PRETAX PROFIT USD 51.785 MILLION VS. IBES ESTIMATE USD 47.9 MILLION
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$阿里拉姆制药(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$阿里拉姆制药(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...
Gapping up
$亚马逊(AMZN.US)$ stock rose 0.5% after the tech giant announced plans to invest up to $4 billion in artificial intelligence group Anthropic, in an attempt to bolster its position in nascent AI technology.
$Warner Bros Discovery(WBD.US)$ stock rose 2.1%, $奈飞(NFLX.US)$ rose 0.8% and $迪士尼(DIS.US)$ rose 1.1% as these entertainment giants benefited from the news that Hollywood's wr...
$Oscar Health(OSCR.US)$ $Local Bounti(LOCL.US)$ $3M(MMM.US)$ $Mullen Automotive(MULN.US)$ $Pyxis Oncology(PYXS.US)$ $LogicMark(LGMK.US)$ $Harmony Biosciences(HRMY.US)$ $Draganfly(DPRO.US)$ $Biomea Fusion(BMEA.US)$ $Helbiz(HLBZ.US)$ $WiSA Technologies(WISA.US)$
$AMC院线(AMC.US)$ $Biodexa Pharmaceuticals(BDRX.US)$ $Biomea Fusion(BMEA.US)$ $Harmony Biosciences(HRMY.US)$ $LogicMark(LGMK.US)$ $Lululemon Athletica(LULU.US)$ $Monopar Therapeutics(MNPR.US)$ $Mullen Automotive(MULN.US)$ $Nogin(NOGN.US)$ $Oscar Health(OSCR.US)$ $普拉格能源(PLUG.US)$ $Standard Lithium(SLI.US)$ $Visa(V.US)$ $WiSA Technologies(WISA.US)$
暂无评论